Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples